查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317843

高血压药物市场：治疗方法、分析、类型和分布划分 - 全球预测 2023-2030

Hypertension Drug Market by Therapy, Analysis, Type, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球抗高血压药物市场预计将大幅成长，2023年将达到268.8亿美元，年复合成长率为8.71%，2030年将达到483.2亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球高血压药物市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球高血压治疗药物市场规模及预测为何？

2.在预测期内，COVID-19对全球高血压药物市场的阻碍因素与影响为何？

3. 在预测期内，全球高血压药物市场需要投资哪些产品/细分市场/用途/领域？

4.全球高血压药物市场的竞争策略为何？

5. 全球抗高血压药物市场的技术趋势和法律规范是什么？

6.全球高血压药物市场主要供应商的市占率为何？

7. 哪些型态和策略措施被认为适合进入全球高血压药物市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 提高对高血压相关併发症的认识
      • 随着人口老化，高血压盛行率增加
      • 高血压药物治疗进展
    • 抑制因素
      • 偏远地区买不到高血压药
    • 机会
      • 扩大私人和政府的研发配合措施
      • 进一步聚焦开发新药
    • 任务
      • 人们越来越担心治疗方案的副作用
      • 替代仿製药的增加
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章高血压药物市场：依治疗方法

  • 介绍
  • α阻断剂
  • 血管紧张素转换酶抑制剂
  • 血管张力素受体阻断剂
  • β阻断剂
  • 钙通道阻断剂
  • 利尿剂
  • 肾素抑制剂

第7章高血压药物市场：分析

  • 介绍
  • 肺动脉高压治疗药
  • 全身性高血压药物

第8章高血压药物市场：依类型

  • 介绍
  • 联合治疗
  • 单一疗法

第9章高血压药物市场：依分布

  • 介绍
  • 医院药房
  • 网路药房
  • 零售药房

第10章北美与南美高血压药物市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太高血压药物市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲高血压药物市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-43127F72799A

The Global Hypertension Drug Market is forecasted to grow significantly, with a projected USD 26.88 billion in 2023 at a CAGR of 8.71% and expected to reach a staggering USD 48.32 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Hypertension Drug Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Hypertension Drug Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Therapy, market is studied across Alpha Blockers, Angiotensin Converting Enzyme Inhibitor, Angiotensin Receptor Blockers, Beta Blockers Vasodilators, Calcium Channel Blockers, Diuretics, and Renin Inhibitors. The Angiotensin Receptor Blockers is projected to witness significant market share during forecast period.

Based on Analysis, market is studied across Pulmonary Hypertension Drugs and Systemic Hypertension Drugs. The Pulmonary Hypertension Drugs is projected to witness significant market share during forecast period.

Based on Type, market is studied across Combination Therapy and Mono Therapy. The Combination Therapy is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Hospital Pharmacy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Hypertension Drug Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Hypertension Drug Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hypertension Drug Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hypertension Drug Market?

4. What is the competitive strategic window for opportunities in the Global Hypertension Drug Market?

5. What are the technology trends and regulatory frameworks in the Global Hypertension Drug Market?

6. What is the market share of the leading vendors in the Global Hypertension Drug Market?

7. What modes and strategic moves are considered suitable for entering the Global Hypertension Drug Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Hypertension Drug Market, by Therapy, 2022 vs 2030
  • 4.3. Hypertension Drug Market, by Analysis, 2022 vs 2030
  • 4.4. Hypertension Drug Market, by Type, 2022 vs 2030
  • 4.5. Hypertension Drug Market, by Distribution, 2022 vs 2030
  • 4.6. Hypertension Drug Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in awareness related to complications associated with hypertension
      • 5.1.1.2. Increasing prevalence of hypertension coupled with geriatric population
      • 5.1.1.3. Advances in pharmacologic treatment of hypertension
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of hypertension drugs in remote areas
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing initiatives by private and government organizations for R&D
      • 5.1.3.2. Increasing focus on development of new drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Increased concern of side-effects of treatment options
      • 5.1.4.2. Rising number of alternate generic drugs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Hypertension Drug Market, by Therapy

  • 6.1. Introduction
  • 6.2. Alpha Blockers
  • 6.3. Angiotensin Converting Enzyme Inhibitor
  • 6.4. Angiotensin Receptor Blockers
  • 6.5. Beta Blockers Vasodilators
  • 6.6. Calcium Channel Blockers
  • 6.7. Diuretics
  • 6.8. Renin Inhibitors

7. Hypertension Drug Market, by Analysis

  • 7.1. Introduction
  • 7.2. Pulmonary Hypertension Drugs
  • 7.3. Systemic Hypertension Drugs

8. Hypertension Drug Market, by Type

  • 8.1. Introduction
  • 8.2. Combination Therapy
  • 8.3. Mono Therapy

9. Hypertension Drug Market, by Distribution

  • 9.1. Introduction
  • 9.2. Hospital Pharmacy
  • 9.3. Online Pharmacy
  • 9.4. Retail Pharmacy

10. Americas Hypertension Drug Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Hypertension Drug Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Hypertension Drug Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HYPERTENSION DRUG MARKET RESEARCH PROCESS
  • FIGURE 2. HYPERTENSION DRUG MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HYPERTENSION DRUG MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2022 VS 2030 (%)
  • FIGURE 5. HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2022 VS 2030 (%)
  • FIGURE 6. HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 7. HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
  • FIGURE 8. HYPERTENSION DRUG MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. HYPERTENSION DRUG MARKET DYNAMICS
  • FIGURE 10. HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HYPERTENSION DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HYPERTENSION DRUG MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HYPERTENSION DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYPERTENSION DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. HYPERTENSION DRUG MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. HYPERTENSION DRUG MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HYPERTENSION DRUG MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HYPERTENSION DRUG MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 5. HYPERTENSION DRUG MARKET SIZE, BY ALPHA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HYPERTENSION DRUG MARKET SIZE, BY ANGIOTENSIN CONVERTING ENZYME INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HYPERTENSION DRUG MARKET SIZE, BY ANGIOTENSIN RECEPTOR BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HYPERTENSION DRUG MARKET SIZE, BY BETA BLOCKERS VASODILATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HYPERTENSION DRUG MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HYPERTENSION DRUG MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HYPERTENSION DRUG MARKET SIZE, BY RENIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 13. HYPERTENSION DRUG MARKET SIZE, BY PULMONARY HYPERTENSION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HYPERTENSION DRUG MARKET SIZE, BY SYSTEMIC HYPERTENSION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. HYPERTENSION DRUG MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. HYPERTENSION DRUG MARKET SIZE, BY MONO THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 19. HYPERTENSION DRUG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. HYPERTENSION DRUG MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. HYPERTENSION DRUG MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HYPERTENSION DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HYPERTENSION DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC HYPERTENSION DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA HYPERTENSION DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM HYPERTENSION DRUG MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM HYPERTENSION DRUG MARKET SIZE, BY ANALYSIS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM HYPERTENSION DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM HYPERTENSION DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. HYPERTENSION DRUG MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 191. HYPERTENSION DRUG MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 192. HYPERTENSION DRUG MARKET LICENSE & PRICING